Novartis Ireland Limited (Novartis Ireland Limited)
Lobbying activity
The following activities occurred for this specific Subject Matter Area.
Email (6-10)
Inviting key DPOs involved to attend and speak at the launch of a multi-stakeholder cardiovascular white paper calling for implementation of a National Cardiovascular Strategy by 2027, improved prevention and screening, and better patient access to care.
Event scheduled for the morning of the 30th September during EU Screening Week.
Designated public officials lobbied
The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.